Research Feed
Dolby Laboratories - IP licensing business model transformation underpriced
Dolby Laboratories (DLB) is a 91% gross margin, asset-light IP licensing business trading at 13.85x forward earnings. Down 22% over the past year and sitting at the 16th percentile of its 52-week range, the market is pricing this as a mature, declining licensing business. The Q1 FY2026 earnings call
Dolby Laboratories Q1 FY2026 — Service Provider Monetization Layer and Vision 2 Royalty Uplift
Dolby Laboratories disclosed material business model expansion in its Q1 FY2026 earnings call on January 29, 2026. The company is adding a consumption-based revenue layer from content service providers, marking a structural shift beyond its historical device OEM licensing model. Service Provider Mon